Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis
Wise, R.M.; Harrison, M.A.A.; Sullivan, B.N.; Al-Ghadban, S.; Aleman, S.J.; Vinluan, A.T.; Monaco, E.R.; Donato, U.M.; Pursell, I.A.; Bunnell, B.A. Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis. Cells 2020, 9, 2218. https://doi.org/10.3390/cells9102218
Wise RM, Harrison MAA, Sullivan BN, Al-Ghadban S, Aleman SJ, Vinluan AT, Monaco ER, Donato UM, Pursell IA, Bunnell BA. Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis. Cells. 2020; 9(10):2218. https://doi.org/10.3390/cells9102218
Chicago/Turabian StyleWise, Rachel M.; Harrison, Mark A.A.; Sullivan, Brianne N.; Al-Ghadban, Sara; Aleman, Sarah J.; Vinluan, Amber T.; Monaco, Emily R.; Donato, Umberto M.; Pursell, India A.; Bunnell, Bruce A. 2020. "Short-Term Rapamycin Preconditioning Diminishes Therapeutic Efficacy of Human Adipose-Derived Stem Cells in a Murine Model of Multiple Sclerosis" Cells 9, no. 10: 2218. https://doi.org/10.3390/cells9102218